Reardon Andrew sold LGND
February 14, 2025 · Form 4 insider transaction
Reardon Andrew sold 1,758 shares of Ligand Pharmaceuticals Incorporated at $120.00 per share, a transaction worth $211.0K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,758
Price
$120.00
Total value
$211.0K
InsiderReardon Andrew
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 14, 2025
Filing dateFebruary 19, 2025
Shares owned after30,358
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of performance stock units.